NeuroSense Therapeutics Shares Are Trading Higher After the Company Announced It Initiated a Process to Seek Early Commercialization Approval for PrimeC in ALS Under Heath Canada's Notice of Compliance With Conditions Policy.
NeuroSense Therapeutics Shares Are Trading Higher After the Company Announced It Initiated a Process to Seek Early Commercialization Approval for PrimeC in ALS Under Heath Canada's Notice of Compliance With Conditions Policy.
NeuroSense Therapeutics股票交易較高，因爲公司宣佈已啓動尋求在加拿大衛生部遵守條件政策下爲ALS的PrimeC獲得提前商業化批准的過程。
NeuroSense Therapeutics Shares Are Trading Higher After the Company Announced It Initiated a Process to Seek Early Commercialization Approval for PrimeC in ALS Under Heath Canada's Notice of Compliance With Conditions Policy.
NeuroSense Therapeutics股票交易較高，因爲公司宣佈已啓動尋求在加拿大衛生部遵守條件政策下爲ALS的PrimeC獲得提前商業化批准的過程。
資訊熱榜
更新時間